D-Glucose monohydrate | CAS:5996-10-1

We serve D-Glucose monohydrate CAS:5996-10-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
 D-Glucose monohydrate

Synonyms:
Corn sugar
C6H12O6.H2O
Dextrose monohydrate
Dextrose,granular
DEXTROSE USP MONOHYDRATE
 
Molecular Formula: C6H14O7
Molecular weight: 198.17100

Appearance and properties: colorless crystal or white crystalline powder
Boiling point: 410.8ºC at 760 mmHg
Melting point: 83ºC
Flash point: 202.2ºC
 
Applications: nutritional medicine, can be used as glucose injection, glucose sodium oxide injection

Items of Analysis Standard of Analysis Test Results
Color and Clarity of Solution The sample solution is clear and not more intensely colored than the reference solution Passes Test
Identification A. Meets the requirement Passes Test
B. Meets the requirement Passes Test
 C. Water 7.5%-9.5% 8.6%
Assay 97.5%-102.0% 99.8%
Related substances Maltose and Isomaltose ≤0.4% 0.07%
Maltotriose ≤0.2% 0.01%
Fructose ≤0.15% 0%
Unspecified ≤0.10% 0.01%
Total Impurities ≤0.5% 0.09%
Conductivity ≤20μS/cm 1.5μS/cm
Dextrin The sample dissolves completely Passes Test
Soluble Starch, Sulfites ≤15ppm <15ppm
Aerobic Plate Count ≤1000cfu/g 10cfu/g
Moulds and Yeasts ≤100cfu/g <10cfu/g
Escherichia Coli Negative Negative
Bacterial Endotoxin ≤1.25Eu/g <0.6Eu/g
Conclusion The products meet the requirements of USP43.
 



Contact us for information like D-Glucose Monohydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DEXTROSE USP MONOHYDRATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dextrose,granular Use and application,D-Glucose Monohydrate technical grade,usp/ep/jp grade.


Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.Ethanone, 1-(1-methyl-1H-pyrrol-2-yl)-2,2-bis(2,4,6-trimethylphenyl)- manufacturer In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.L-Phenylalanine, 1-[(3,4-dimethoxyphenyl)sulfonyl]-L-prolyl-4-bromo- supplier Chung also said South Korean citizens who had visited the province in the past 14 days should voluntarily quarantine themselves at home for two weeks after they arrive back into the country.10-Iodo-1-decanol vendor Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities.